Abstract:Fracture remains one of the most common traumatic conditions in orthopedic surgery. The use of mesenchymal stem cells (MSCs) to augment fracture repair is promising. Leucine-rich repeat-containing GPCR 5 (Lgr5), a transmembrane protein, has been identified as a novel adult stem cell marker in various organs and tissues. However, the roles of Lgr5 in MSCs are not fully understood. In this study, we investigated cellular functions of Lgr5 in MSCs and its potential implications in treating fracture. Lgr5-overexpressing MSCs (MSCLgr5) were established in murine SV40 promoter-driven luciferase reporter MSC line through virus transfection. Results of real-time quantitative PCR and Western blot analysis confirmed the increased expression of Lgr5 in MSCLgr5. MSCLgr5 exhibited increased osteogenic capacity, which may result from elevated expression of beta-catenin and phosphorylated ERK1/2 within the nuclear region of cells. In contrast, inhibition of Lgr5 expression decreased the osteogenic differentiation ability of MSCs, accompanied with increased mitochondrial fragmentation and reduced expression of beta-catenin. Local transplantation of MSCLgr5 at fracture sites accelerated fracture healing via enhanced osteogenesis and angiogenesis. MSCLgr5 stimulated the tube formation capacity of HUVECs in a Matrigel coculture system in vitro significantly. Taken together, results suggest that Lgr5 is implicated in the cellular processes of osteogenic differentiation of MSCs through regulation of Wnt and ERK signaling pathways and mitochondrial dynamics in fusion and fission. Inhibition of Lgr5 expression induced increased mitochondrial fragmentation and suppression of osteogenesis. MSCLgr5 exhibited enhanced therapeutic efficacy for fracture healing, which may serve as a superior cell source for bone tissue repair.-Lin, W., Xu, L., Pan, Q., Lin, S., Feng, L., Wang, B., Chen, S., Li, Y., Wang, H., Li, Y., Wang, Y., Lee, W. Y. W., Sun, D., Li, G. Lgr5-overexpressing mesenchymal stem cells augment fracture healing through regulation of Wnt/ERK signaling pathways and mitochondrial dynamics.

Loss of Lgr4 Inhibits Differentiation, Migration and Apoptosis, and Promotes Proliferation in Bone Mesenchymal Stem Cells

Lgr4 promotes aerobic glycolysis and differentiation in osteoblasts via the canonical Wnt/-catenin pathway

Lgr4 promotes aerobic glycolysis and differentiation in osteoblasts via the canonical Wnt/β ‐catenin pathway

LGR4 Modulates Breast Cancer Initiation, Metastasis, and Cancer Stem Cells

Lgr4 is a key regulator of prostate development and prostate stem cell differentiation.

Lgr4 Regulates Mammary Gland Development and Stem Cell Activity Through the Pluripotency Transcription Factor Sox2

LGR4, Not LGR5, Enhances Hpsc Hematopoiesis by Facilitating Mesoderm Induction Via TGF-Beta Signaling Activation.

Lgr5-overexpressing Mesenchymal Stem Cells Augment Fracture Healing Through Regulation of Wnt/ERK Signaling Pathways and Mitochondrial Dynamics

Lgr4 deficiency attenuates tumor formation by reprograming macrophage polarization in lung cancer (TUM6P.973)

Leucine-rich Repeat-containing G-protein-coupled Receptor 5 Marks Short-term Hematopoietic Stem and Progenitor Cells During Mouse Embryonic Development

LRP6 in mesenchymal stem cells is required for bone formation during bone growth and bone remodeling

LMCD1 Promotes Osteogenic Differentiation of Human Bone Marrow Stem Cells by Regulating BMP Signaling

G protein-coupled receptor kinase 3 modulates mesenchymal stem cell proliferation and differentiation through sphingosine-1-phosphate receptor regulation

Lgr4 Deletion Delays the Hair Cycle and Inhibits the Activation of Hair Follicle Stem Cells

LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption

From Marrow to Bone and Fat: Exploring the Multifaceted Roles of Leptin Receptor Positive Bone Marrow Mesenchymal Stromal Cells

Lrp4 In Osteoblasts Suppresses Bone Formation And Promotes Osteoclastogenesis And Bone Resorption

Leukemia Inhibitory Factor Facilitates Self-Renewal and Differentiation and Attenuates Oxidative Stress of BMSCs by Activating PI3K/AKT Signaling

Signaling pathways associated with Lgr6 to regulate osteogenesis

Lamc1 promotes osteogenic differentiation and inhibits adipogenic differentiation of bone marrow-derived mesenchymal stem cells

Downregulating LKB1 in bone marrow mesenchymal stem cells could inhibit CD4 + T cell proliferation via the PD-1/PD-L1 signaling pathway